ArcaScience
French tech company | Builders Republic
About
Healthtech building an AI platform that automates benefit-risk assessment of drug candidates for pharma companies and regulators — combining specialized models trained on a vast biomedical knowledge base to evaluate safety and efficacy trade-offs, sold to drug developers and now extended to patient-facing decision support.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2018
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 6.0 M€ raised since 2020
Funding rounds
- Series A — 2025